The rising interest in effective weight management has spurred considerable research into cutting-edge treatments. Lately , Retatrutide, a twin-action glucose-dependent insulinotropic polypeptide (GIP) and peptide receptor stimulator, has demonstrated encouraging results in medical trials, implyi